Hedge Fund Sentiment Says You Should Be Wary of One of these Three Tuesday Gainers

Page 2 of 2

Ceres Inc (NASDAQ:CERE)’s shares were over 31% in green, after the firm announced that KWS SAAT SE has licensed the firm’s Persephone bioinformatics technology. Under the agreement, KWS SAAT SE will be examining the technology, which lets researchers study DNA-related information in a manner similar to how mapping technology lets users to explore locations.

Follow Ceres Inc. (NASDAQ:CERE)

Ceres Inc (NASDAQ:CERE) is a company that has been under the radars of most large investors. Ken Griffin’s Citadel Investment Group closed its stake during the second quarter, making Jim Simons’ Renaissance Technologies the only shareholder of Ceres shares among the hedge funds Insider Monkey tracks. However, Renaissance’s stake was reduced by 86% quarter-over-quarter to 90,673 shares.

Meanwhile, Rockwell Medical Inc (NASDAQ:RMTI)’s stock is up nearly 20% today after a decline of over 15% on Monday, on the back of Oppenheimer reiterating its ‘Buy’ rating and $26 per share price target on the stock. According to analyst Ling Wang, shares of the biopharmaceutical firm have declined significantly, which represents a good entry point for potential investors, especially since the price is below the level reached when the company’s drug Triferic was approved. The analyst also cited potential ramp ups in Triferic and Calcitriol in the second half of 2015 as possible catalysts for the stock’s growth. Triferic was only launched in the U.S. two weeks ago.

Follow Rockwell Medical Inc. (NASDAQ:RMTI)

Rockwell Medical Inc (NASDAQ:RMTI)’s stock improved by 47.48% in the second quarter, but the value of hedge funds’ holdings only increased by 5.81% from the previous quarter to $18.85 million. There were also three fewer funds which had long positions in the stock bringing this figure down to eight at the end of the second quarter. Bihua Chen’s Cormorant Asset Management was the largest shareholder with a stake of 340,000 shares. On the other hand, Peter Muller’s PDT Partners dumped all of its 47,952 shares of Rockwell, that it had acquired a quarter earlier.

Disclosure: None

Page 2 of 2